Cognizant CTSH Health Sciences — Goodwill, Acquired During Period
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cognizant in its filing.
Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.
The official record: Cognizant’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cognizant's health sciences — goodwill, acquired during period.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cognizant's health sciences — goodwill, acquired during period?
- Cognizant (CTSH) reported health sciences — goodwill, acquired during period of $0 in Q4 2025.
- How has Cognizant's health sciences — goodwill, acquired during period changed year-over-year?
- Cognizant's health sciences — goodwill, acquired during period decreased by 100.0% year-over-year, from $17M to $0.
- What is the long-term trend for Cognizant's health sciences — goodwill, acquired during period?
- Over 4 years (2021 to 2025), Cognizant's health sciences — goodwill, acquired during period has grown at a -100.0% compound annual growth rate (CAGR), from $84M to $0.
- What does health sciences — goodwill, acquired during period mean?
- This metric tracks the specific amount of goodwill recognized on the balance sheet resulting from business combinations completed within the Health Sciences segment during the current reporting period. It highlights the company's commitment to inorganic expansion and strategic consolidation within the healthcare technology market. This figure is a key indicator of the capital deployed to acquire new capabilities, talent, or market share.